171 related articles for article (PubMed ID: 19694612)
21. Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.
Pourjavadi A; Tehrani ZM; Moghanaki AA
Pharm Res; 2016 Feb; 33(2):417-32. PubMed ID: 26438181
[TBL] [Abstract][Full Text] [Related]
22. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.
Celia C; Cosco D; Paolino D; Fresta M
Expert Opin Drug Deliv; 2011 Dec; 8(12):1609-29. PubMed ID: 22077480
[TBL] [Abstract][Full Text] [Related]
24. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
25. Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice.
Xu Y; Meng H; Du F; Lu W; Liu S; Huang J; Yu J
Int J Pharm; 2015 Nov; 495(2):792-7. PubMed ID: 26410754
[TBL] [Abstract][Full Text] [Related]
26. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
[TBL] [Abstract][Full Text] [Related]
27. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
Yilmaz S; Ichedef C; Karatay KB; Teksöz S
Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192
[TBL] [Abstract][Full Text] [Related]
28. Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention.
Garg NK; Dwivedi P; Campbell C; Tyagi RK
Eur J Pharm Sci; 2012 Dec; 47(5):1006-14. PubMed ID: 23041219
[TBL] [Abstract][Full Text] [Related]
29. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
[TBL] [Abstract][Full Text] [Related]
30. Preparation and in vitro assessment of wet-spun gemcitabine-loaded polymeric fibers: Towards localized drug delivery for the treatment of pancreatic cancer.
Wade SJ; Zuzic A; Foroughi J; Talebian S; Aghmesheh M; Moulton SE; Vine KL
Pancreatology; 2017; 17(5):795-804. PubMed ID: 28619283
[TBL] [Abstract][Full Text] [Related]
31. Efficient "green" encapsulation of a highly hydrophilic anticancer drug in metal-organic framework nanoparticles.
Rodriguez-Ruiz V; Maksimenko A; Anand R; Monti S; Agostoni V; Couvreur P; Lampropoulou M; Yannakopoulou K; Gref R
J Drug Target; 2015; 23(7-8):759-67. PubMed ID: 26453171
[TBL] [Abstract][Full Text] [Related]
32. 5-Fluorouracil-loaded iron/ethylcellulose (core/shell) nanoparticles for active targeting of cancer.
Arias JL; López-Viota M; Delgado AV; Ruiz MA
J Drug Target; 2009 Sep; ():. PubMed ID: 19725757
[TBL] [Abstract][Full Text] [Related]
33. Antitumor gemcitabine conjugated micelles from amphiphilic comb-like random copolymers.
Wang J; Zhang X; Cen Y; Lin X; Wu Q
Colloids Surf B Biointerfaces; 2016 Oct; 146():707-15. PubMed ID: 27434158
[TBL] [Abstract][Full Text] [Related]
34. Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388.
Marańda E; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(2):113-9. PubMed ID: 9613709
[TBL] [Abstract][Full Text] [Related]
35. Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy.
Heyder RS; Sunbul FS; Almuqbil RM; Fines CB; da Rocha SRP
J Control Release; 2021 Feb; 330():1178-1190. PubMed ID: 33212118
[TBL] [Abstract][Full Text] [Related]
36. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery.
Parsian M; Mutlu P; Yalcin S; Gunduz U
Anticancer Agents Med Chem; 2020; 20(10):1233-1240. PubMed ID: 32156242
[TBL] [Abstract][Full Text] [Related]
38. Study of carbonyl iron/poly(butylcyanoacrylate) (core/shell) particles as anticancer drug delivery systems Loading and release properties.
Arias JL; Linares-Molinero F; Gallardo V; Delgado AV
Eur J Pharm Sci; 2008 Mar; 33(3):252-61. PubMed ID: 18249100
[TBL] [Abstract][Full Text] [Related]
39. Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles.
Jia L; Zheng JJ; Jiang SM; Huang KH
World J Gastroenterol; 2010 Feb; 16(8):1008-13. PubMed ID: 20180242
[TBL] [Abstract][Full Text] [Related]
40. pH-Sensitive Nanoparticles Composed Solely of Membrane-Disruptive Macromolecules for Treating Pancreatic Cancer.
Fan F; Jin L; Yang L
ACS Appl Mater Interfaces; 2021 Mar; 13(11):12824-12835. PubMed ID: 33689289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
